Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > KOD Kodiak Sciences > Detailed Quotes

KOD Kodiak Sciences

8.040
+0.430+5.65%
Close 09/28 16:00 ET
7.800
-0.240-2.99%
Post Mkt Price 09/28 18:43 ET
High
8.445
Open
7.820
Turnover
6.30M
Low
7.820
Pre Close
7.610
Volume
773.74K
Market Cap
418.40M
P/E(TTM)
Loss
52wk High
131.970
Shares
52.04M
P/E(Static)
Loss
52wk Low
4.900
Float Cap
250.31M
Bid/Ask %
66.67%
Historical High
171.210
Shs Float
31.13M
Volume Ratio
1.43
Historical Low
4.900
Dividend TTM
--
Div Yield TTM
--
P/B
0.79
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.49%
Amplitude
8.21%
Avg Price
8.142
Lot Size
1
Float Cap
250.31M
Bid/Ask %
66.67%
Historical High
171.210
Shs Float
31.13M
Volume Ratio
1.43
Historical Low
4.900
Dividend TTM
--
P/B
0.79
Dividend LFY
--
Turnover Ratio
2.49%
Amplitude
8.21%
Avg Price
8.142
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
CEO: Dr. Victor Perlroth, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...